Skip to Main Content

Paper Details

Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Cancer Discov
49
2015
EGFR, EGFR kinase domain, EGFR protein, EGFR-mutant human lung adenocarcinoma cell lines, ERBB, MIG6, Mig6, Mig6 haploinsufficiency, Mutant EGFR, Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma, human, lung adenocarcinoma, lung tumor, mice, mouse, mutant EGFR, mutant EGFRs, tumor, tyrosine
Author NameAffiliation
Tapan K MaityCenter for Cancer Research
Constance M CultraroCenter for Cancer Research
Xu ZhangCenter for Cancer Research
Deborah K Morrison
Harold VarmusMemorial Sloan Kettering Cancer Center
Udayan GuhaCenter for Cancer Research, Memorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets